Search Results - "Mistretta F"

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

TERRESTRIAL LASER SCANNER FOR MONITORING THE DEFORMATIONS AND THE DAMAGES OF BUILDINGS.

Authors: Vacca, G. Mistretta, F. Stochino, F. et al.

Source: International Archives of the Photogrammetry, Remote Sensing & Spatial Information Sciences; 2016, Vol. 41 Issue B5, p453-460, 8p

A0257 - Predicting the risk of biochemical recurrence at five years in patients treated with radical prostatectomy for prostate cancer: The PIPEN categories.

Authors: Luzzago, S. Mistretta, F. Piccinelli, M.L. et al.

Source: European Urology. Feb2023:Supplement 1, Vol. 83, pS366-S366. 1p.

This result is not displayed to guests.
Login for full access.

SC231 - A comparison between trans-rectal ultrasound-guided MRI-fusion versus MRI-cognitive versus standard prostate biopsies performed at the same time, in the same patient: Concordance rate and clinically significant prostate cancer detection.

Authors: Conti, A. Mistretta, F. Musi, G. et al.

Source: European Urology Supplements. Oct2019, Vol. 18 Issue 9, pe3295-e3296. 2p.

SC109 - A comprehensive evaluation of sexual disorders following robot-assisted retroperitoneal lymph node dissection for non-seminomatous germ cell tumour.

Authors: Mistretta, F. Musi, G. Conti, A. et al.

Source: European Urology Supplements. Oct2019, Vol. 18 Issue 9, pe3220-e3221. 2p.

SC86 - Percutaneous image-guided radiofrequency ablation for cT1a-b renal masses: A comparison between patients younger vs. older than 65 years.

Authors: Mistretta, F. Mauri, G. Piacentini, N. et al.

Source: European Urology Supplements. Oct2019, Vol. 18 Issue 9, pe3209-e3209. 1p.

P169 - Oligometastatic prostate cancer: The importance of a multidisciplinary approach in a high volume robotic center.

Authors: Mistretta, F. Conti, A. Catellani, M. et al.

Source: European Urology Supplements. Sep2018, Vol. 17 Issue 8, p276-276. 1p.

V4 - Robot-Assisted vesical fistula repair: A multiistitutional experience.

Authors: Matei, D. Mistretta, F. Zanagnolo, V. et al.

Source: European Urology Supplements. Sep2018, Vol. 17 Issue 8, p182-182. 1p.

V2 - Feasibility of a novel port placement technique for robotic retroperitoneal salvage lymph node dissection for testicular cancer.

Authors: Conti, A. Mistretta, F. Luzzago, S. et al.

Source: European Urology Supplements. Sep2018, Vol. 17 Issue 8, p173-173. 1p.

98 Long-term oncologic outcomes of laparoscopic renal cryoablation: 10 years results from a single institution.

Authors: Larcher, A. Mistretta, F. Fossati, N. et al.

Source: European Urology Supplements. Apr2014, Vol. 13 Issue 1, pe98-e98. 1p.

583 Definition of mid-term MRI follow-up after focal therapy for clinically localized low risk prostate cancer.

Authors: Mistretta, F. Losa, A. Cardone, G. et al.

Source: European Urology Supplements. Mar2013, Vol. 12 Issue 1, pe583-e584. 0p.

MSR86 Use of Data Linkage for the Evaluation of Medical Devices: A Systematic Literature Review.

Authors: Gougeon, A. Bernard, A. Mistretta, F. et al.

Source: Value in Health. 2023 Supplement, Vol. 26 Issue 12, pS409-S409. 1p.

P206 - In-bore magnetic resonance (mpMRI)-guided biopsies represent the future of prostate cancer diagnosis? A single center experience and implications for focal therapy.

Authors: Luzzago, S. Catellani, M. Mistretta, F. et al.

Source: European Urology Supplements. Sep2018, Vol. 17 Issue 8, p309-310. 2p.

P87 - Multiparametric magnetic resonance (mpMRI) of the prostate during active surveillance for low-risk prostate cancer: Time to reduce the number of follow-up biopsies?.

Authors: Luzzago, S. Catellani, M. Mistretta, F. et al.

Source: European Urology Supplements. Sep2018, Vol. 17 Issue 8, p220-221. 2p.

P81 - Low risk prostate cancer in the contemporary magnetic-resonance ERA: Are we excluding too much patients suitable for active surveillance?.

Authors: Catellani, M. Luzzago, S. Mistretta, F. et al.

Source: European Urology Supplements. Sep2018, Vol. 17 Issue 8, p217-218. 2p.

PRO77 Sequence Analysis of Cystic Fibrosis Care Management Pathway: A Population-Study Based on the French National Claims Databases.

Authors: Soubeiga, A. Portugues, C. Mistretta, F. et al.

Source: Value in Health. 2020 Supplement 2, Vol. 23, pS703-S703. 1p.

P90 - Oncological outcomes and management changes over A 13 years experience on active surveillance for low-risk prostate cancer. Results of a single high-volume center.

Authors: Catellani, M. Luzzago, S. Mistretta, F. et al.

Source: European Urology Supplements. Sep2018, Vol. 17 Issue 8, p222-222. 1p.

Epidemiology, management, and prognosis of secondary non-postoperative peritonitis: a French prospective observational multicenter study.

Authors: Gauzit R Péan Y Barth X et al.

Source: Surgical Infections. Apr2009, Vol. 10 Issue 2, p119-127. 9p.